title: TORC2 inhibition may boost DNA-damaging chemotherapy.
abstract: Comment on: Selvarajah J, Elia A, Carroll VA, Moumen A. DNA damage-induced S and G2/M cell cycle arrest requires mTORC2-dependent regulation of Chk1. Oncotarget. 2015; 6:427-40.
authors.affiliation: Department of Gynecology, University of Zurich, Schlieren, Switzerland.
authors.forename: Manuel
authors.initials: M
authors.lastname: Stucki
mesh_terms: D001943:Breast Neoplasms / Q000473:pathology*; D002470:Cell Survival / Q000502:physiology*; D004249:DNA Damage / Q000502:physiology*; D006801:Humans; D046912:Multiprotein Complexes / Q000378:metabolism*; D011494:Protein Kinases / Q000378:metabolism*; D058570:TOR Serine-Threonine Kinases / Q000378:metabolism*
chemical_list: D046912:Multiprotein Complexes; D011494:Protein Kinases; D058570:TOR Serine-Threonine Kinases